RG
BGMS icon

Redmile Group’s Bio Green Med Solution Inc BGMS Stock Holding History

Redmile Group’s Portfolio BGMS Stock Details BGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-1
Closed -$3.18M – 54
2013
Q2 		$3.18M Buy
+1
New +$3.41M 0.56% 39

Other funds holding BGMS

Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CCA
Catalyst Capital Advisors Huntington, New York $6.03B AUM 24.5% 1-Year Est. Return
IPC
Invesco Private Capital New York $365M AUM 8.08% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Redmile Group's BGMS Position: Q3 2013 in Review

Redmile Group sold out of Bio Green Med Solution Inc (BGMS) in Q3 2013, closing a stake of 1 share — an estimated $3.18M sold.

Redmile Group first reported a position in BGMS in Q2 2013 and held it in 1 quarter. The position peaked at $3.18M in Q2 2013. 2 funds tracked by Wall St. Rank hold BGMS as of Q3 2013.

  • Redmile Group reported no remaining Bio Green Med Solution Inc position as of Q3 2013 after selling out during the quarter.
  • Redmile Group sold 1 Bio Green Med Solution Inc share in Q3 2013, an estimated $3.18M.
  • Redmile Group first reported a position in Bio Green Med Solution Inc in Q2 2013 and held it in 1 quarter.
  • Redmile Group's Bio Green Med Solution Inc position peaked at $3.18M in Q2 2013.
  • 2 funds tracked by Wall St. Rank held Bio Green Med Solution Inc as of Q3 2013.

Based on Redmile Group's 13F filing for Q3 2013, filed 14 Nov 2013.